Literature DB >> 26600937

Does St. John's Wort cause regression in gastrointestinal system adenocarcinomas?

Serap Karaarslan1, Suna Cokmert1, Atilla Cokmez1.   

Abstract

St. John's Wort (SJW) is an old herb which has long been consumed widely for its anti-inflammatory, antiviral, and anti-depressive properties. Here we present a detailed clinical evaluation of three cases (two colon and one duodenal adenocarcinoma) with remarkable and intensive lymphoplasmocytic host reaction, at the basal part of tumor, intensive fibrosis, giant cells, plasma cell increase in lymph nodes and few giant cells in germinal centers in resection specimens. The observation of similar host reaction in those tumors having otherwise usual appearance was interesting. None of the cases received neoadjuvant chemoradiotherapy or additional treatment before surgery but only SJW. These cases are presented to increase the awareness about such cases. Further research is needed to reveal the possible effect of SJW, which has long been consumed for different treatment purposes, on human tumors.

Entities:  

Keywords:  Adenocarcinoma; Giant cell; St. John’s Wort

Year:  2015        PMID: 26600937      PMCID: PMC4644860          DOI: 10.4251/wjgo.v7.i11.369

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  23 in total

Review 1.  Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology.

Authors:  P J Nathan
Journal:  J Psychopharmacol       Date:  2001-03       Impact factor: 4.153

2.  Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort.

Authors:  James C Milton; Aza Abdulla
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

Review 3.  Topical application of St. John's wort (Hypericum perforatum).

Authors:  Ute Wölfle; Günter Seelinger; Christoph M Schempp
Journal:  Planta Med       Date:  2013-11-08       Impact factor: 3.352

Review 4.  Hypericin in cancer treatment: more light on the way.

Authors:  Patrizia Agostinis; Annelies Vantieghem; Wilfried Merlevede; Peter A M de Witte
Journal:  Int J Biochem Cell Biol       Date:  2002-03       Impact factor: 5.085

Review 5.  Role of hyperforin in the pharmacological activities of St. John's Wort.

Authors:  Paola Zanoli
Journal:  CNS Drug Rev       Date:  2004

6.  Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.

Authors:  Evangeli S Lampri; Elli Ioachim; Haralampos Harissis; Eufemia Balasi; Antigoni Mitselou; Vasiliki Malamou-Mitsi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.

Authors:  Katarina Hostanska; Juergen Reichling; Silvia Bommer; Michel Weber; Reinhard Saller
Journal:  Eur J Pharm Biopharm       Date:  2003-07       Impact factor: 5.571

Review 8.  St John's wort for major depression.

Authors:  Klaus Linde; Michael M Berner; Levente Kriston
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

9.  Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A.

Authors:  Veronika Sačková; Lucia Kuliková; Martin Kello; Ivana Uhrinová; Peter Fedoročko
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

Review 10.  Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.

Authors:  Kurt Putnik; Peter Stadler; Christof Schäfer; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2006-09-01       Impact factor: 3.481

View more
  2 in total

1.  Antiproliferative Effects of Free and Encapsulated Hypericum Perforatum L. Extract and Its Potential Interaction with Doxorubicin for Esophageal Squamous Cell Carcinoma.

Authors:  Issa Amjadi; Mohammad Mohajeri; Andrei Borisov; Motahare-Sadat Hosseini
Journal:  J Pharmacopuncture       Date:  2019-06-30

2.  Hyperforin and Myrtucommulone Derivatives Act as Natural Modulators of Wnt/β-Catenin Signaling in HCT116 Colon Cancer Cells.

Authors:  Aneliya Knauthe; Sonnhild Mittag; Laura Bloch; Kai Frederik Albring; Martin Schmidt; Oliver Werz; Otmar Huber
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.